Blade Air Mobility has confirmed today the expansion of its organ transportation business, with the addition of 14 transplant centres and Organ Procurement Organizations in the U.S. During 2022, Blade’s MediMobility division will serve more than 40 hospital clients across 20 states.
Operations expand to Maryland, Virginia, Arkansas and Oklahoma; new clients include Mount Sinai's recently launched lung program and Piedmont HospitalAdditional dedicated aircraft, owned and operated by third parties and available coast-to-coast, will serve both Blade’s individual consumer fliers and medical clientsExpansion follows Blade’s acquisition of Trinity Medical Solutions and solidifies the company’s position as the largest dedicated air transporter of human organs for transplant in the United States
Scott Wunsch, COO of Blade MediMobility said, "Our expanded footprint provides immediate benefits for all of the transplant centres and OPOs we serve. By leveraging the growing buying power of both Blade’s individual consumer fliers and hospital clients, we have secured dedicated access to more aircraft in more locations at very favorable rates. Additionally, we can now offer standby access to aircraft in new geographies, enabling unprecedented flexibility to pursue organs that might otherwise go unused. This is a significant value add to our clients, especially given the tight availability of certain types of charter aircraft currently."
"Our integrated, the multimodal offering enables transplant programs to reduce organ transport time and cost, resulting in improved patient and program outcomes. Blade's last-mile offering, currently serviced by captive helicopters and ambulances, continues to expand with these new hospital additions,” said Will Heyburn, CFO of Blade. “We are leveraging our unmatched scale in critical last-mile delivery to push towards a transition to drones and Electric Vertical Aircraft, or EVA, enabling further reduced transport time and cost.”
Mr Heyburn added, “Given the existing on-site landing pad infrastructure at most of our client hospitals as well as our EVA manufacturer partnerships, we believe our MediMobility division is well-positioned to utilize these new aircraft as soon as they are available for commercial use, reducing our hospital partners’ need for intermodal ground transport.”
Follow this site here.
